Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02487550 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal cell carcinoma, and to evaluate the clinical effect of the regimen.
Trial Details
NCT Number NCT02487550
Lead Sponsor The First People's Hospital of Changzhou
Conditions
(from sponsor)		 Renal Neoplasma
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov